Considering the TGF-β signaling pathway is associated with angiogenesis and metabolism of ECM, we suggest that the dysregulation of TGF-β signaling pathways can lead to metabolic disorder of ECM, which may cause excessive proliferation of vasculature and immature vascular development, resulting in tiny vessels scattered within normal brain tissues. The gene discussed is TGFB1; the disease is metabolic disease.